Reata Pharmaceuticals, Inc. RETA
172.36 0.00 (+0.00%)
At closeSep 25, 2023, 4:00 PM EDT
172.32 Day range 172.46
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 2.22M | 11.49M | 9.02M | 26.52M | 53.59M | |
| 2.22M | 11.49M | 9.02M | 26.52M | 53.59M | |
| -278.03M | -244.71M | -226.32M | -285.22M | -76.88M | |
| -311.90M | -297.39M | -247.75M | -290.17M | -80.55M | |
| -8.54 | -8.19 | -7.35 | -9.54 | -2.91 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 42.31M | 590.26M | 818.15M | 664.32M | 337.79M | |
| 514.49M | 735.02M | 857.60M | 682.42M | 345.21M | |
| 580.19M | 549.03M | 440.17M | 425.56M | 330.05M | |
| 119.46M | 136.03M | 5.32M | 155.02M | 79.22M | |
| -65.69M | 185.99M | 417.43M | 256.86M | 15.16M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -204.27M | -235.70M | -322.34M | -251.15M | -83.78M | |
| -345.16M | -1.33M | -927.00K | -2.67M | -679.00K | |
| 1.49M | 9.14M | 477.09M | 580.36M | 292.47M | |
| -3.27M | -1.33M | -927.00K | -2.67M | -679.00K | |
| -547.95M | -227.89M | 153.83M | 326.53M | 208.01M |